The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vedixal XL 75mg Prolonged release capsules, hard

75 milligram(s) Prolonged-release capsule

Aurobindo Pharma (Malta) LimitedPA1445/016/001

Main Information

Trade NameVedixal XL 75mg Prolonged release capsules, hard
Active SubstancesVenlafaxine hydrochloride
Strength75 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/016/001

Group Information

ATC CodeN06AX Other antidepressants
N06AX16 venlafaxine

Status

Authorised/WithdrawnAuthorised
Licence Issued06/03/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0026-028-030
Interchangeable List DocumentPDF of Interchangeable List
« Back